CD44 and breast carcinoma: CD44+/CD24-/Lin- cells from primary breast cancers progress to CD44+/CD24+, CD44-/CD24+, and CD44-/CD24- phenotypes when implanted into mammary fat pad of nonobese diabetic/severe combined immunodeficiency mice [9].